Aktive Positionen von G. Wesley Hatfield
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Actavalon, Inc.
 Actavalon, Inc. Pharmaceuticals: MajorHealth Technology Actavalon, Inc. operates as a preclinical stage pharmaceutical company. It focuses on the development of a single, broad spectrum, drug with the potential to target and eradicate human cancer cells of all types such as breast, lung, pancreatic and colon cancer among others. The company was founded by Ned Israelsen and Wesley G. Hatfield and is headquartered in San Diego, CA. | Direktor/Vorstandsmitglied | - | - |
| Gründer | - | - | |
| Vorstandsvorsitzender | - | - |
Karriereverlauf von G. Wesley Hatfield
Ehemalige bekannte Positionen von G. Wesley Hatfield
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Verdezyne, Inc.
 Verdezyne, Inc. Pharmaceuticals: OtherHealth Technology Verdezyne, Inc. operates as an industrial biotechnology company. It designs and engineers enzymes, metabolic pathways, and microorganisms that produce target chemicals. The firm offers Biolon DDDA, Adipic acid, and Sebacic Acid. The company was founded in 2005 and is headquartered in Carlsbad, CA. | Gründer | 01.01.2005 | - |
Statistik
International
| Vereinigte Staaten | 3 |
Operativ
| Founder | 2 |
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
Sektoral
| Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Verdezyne, Inc.
Verdezyne, Inc. Pharmaceuticals: OtherHealth Technology Verdezyne, Inc. operates as an industrial biotechnology company. It designs and engineers enzymes, metabolic pathways, and microorganisms that produce target chemicals. The firm offers Biolon DDDA, Adipic acid, and Sebacic Acid. The company was founded in 2005 and is headquartered in Carlsbad, CA. | Health Technology |
Actavalon, Inc.
Actavalon, Inc. Pharmaceuticals: MajorHealth Technology Actavalon, Inc. operates as a preclinical stage pharmaceutical company. It focuses on the development of a single, broad spectrum, drug with the potential to target and eradicate human cancer cells of all types such as breast, lung, pancreatic and colon cancer among others. The company was founded by Ned Israelsen and Wesley G. Hatfield and is headquartered in San Diego, CA. | Health Technology |
- Börse
- Insiders
- G. Wesley Hatfield
- Erfahrung
